RxDoctor Payments DataLook up a doctor →

Mark Leibowitz

Internal Medicine · Long Beach, CANPI 1144352907

Payments from drug & device makers

$7,557,483in general payments, 2019–2025

Across 880 payments — averaging $8588.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$3.3M
  • Eli Lilly$1.6M
  • Sanofi Pasteur Inc.$976K
  • Sanofi US Services Inc.$542K
  • AstraZeneca$267K
  • Regeneron$185K
  • plus $685K from 18 others
$98,282in research payments, 2019–2025

Across 21 payments — averaging $4680.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$89K
  • AbbVie$8K
  • Corcept Therapeutics$928

What the payments were for

  • Consulting fees$2004%
  • Travel & lodging$3,57773%
  • Food & beverage$1,10022%
  • Education$321%
  • Gifts$200%

General payments by program year

19
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,557,483 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Other internal medicine in Long Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →